Bank Of America Corp Mirati Therapeutics, Inc. Call Options Transaction History

Bank Of America Corp

  • $1.19 Trillion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$41.99 - $62.38 $6.8 Million - $10.1 Million
162,000 New
162,000 $9.52 Million
Q3 2022

Nov 14, 2022
BUY
$59.5 - $86.7 $23.8 Million - $34.7 Million
400,000 New
400,000 $27.9 Million
Q1 2022

May 16, 2022
BUY
$75.82 - $150.97 $947,749 - $1.89 Million
12,500 Added 1562.5%
13,300 $1.09 Million
Q3 2021

Nov 15, 2021
SELL
$132.13 - $177.45 $52,852 - $70,980
-400 Reduced 33.33%
800 $142,000
Q2 2021

Sep 13, 2021
BUY
$144.0 - $179.73 $172,800 - $215,676
1,200 New
1,200 $194,000

Others Institutions Holding MRTX

# of Institutions
16
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email